Purchase Order HHSP233201700078A

The National Cancer Institute awarded a $1,995,119 firm-fixed-price Phase II SBIR contract to Boston Cell Standards Inc., a for-profit manufacturer of medical devices, diagnostics, and related services. The contract, which is set aside for small businesses, is to develop quantitative traceable reference materials for use in cancer detection and diagnostics. This award builds on a previous $385,889 Phase I SBIR contract with the National Cancer Institute. Boston Cell Standards has also received...

This contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance), a non-profit medical research organization. The contract, valued at $109,264.00, is for the National Cancer Institute's Patterns of Care Study to collect data on diagnosis year 2020 breast and colorectal cancer cases, including the use of biomarker tests, targeted therapies, adjuvant...

The National Cancer Institute (NCI), part of the Department of Health and Human Services, awarded a $244,943 firm fixed-price purchase order contract to the Public Health Institute, a non-profit organization, to conduct the NCI Patterns of Care Study for prostate cancer, ovarian cancer, and small intestines cancer diagnosed in 2021. The contract, which has no set-aside designation, will involve abstracting medical records to describe cancer treatment patterns, compare treatments over time and...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, for the NCI Patterns of Care Study focused on prostate cancer, ovarian cancer, and small intestine cancer diagnosed in 2021. The $104,718 contract runs from May 1, 2024 through April 30, 2025 and does not have a set-aside designation. The study aims to describe the...

The National Cancer Institute (NCI) has awarded the North American Association of Central Cancer Registries Inc. (NAACCR), a non-profit organization, a $16 million indefinite-delivery, indefinite-quantity (IDIQ) contract to provide support services in developing and promoting methods and standards for cancer registry operations and surveillance data. This IDIQ contract, awarded on July 1, 2021, with an ultimate completion date of June 30, 2026, encompasses four main task areas: project...

This federal contract award from the National Cancer Institute (NCI) provides the American College of Surgeons (ACS), a non-profit organization, with access to the 8th Edition of the Cancer Staging Manual and Version 9 Cancer Staging System. This purchase order, valued at $718,331, allows the NCI's Surveillance, Epidemiology, and End Results (SEER) Program to continue collecting and reporting cancer staging data from SEER registries. The contract has a firm-fixed price and a completion date of...

This federal contract award is for a license to use the content of the American Joint Committee on Cancer (AJCC) Cancer Staging System, including API access. The contract was awarded to the American College of Surgeons (ACS), a non-profit organization, by the National Cancer Institute (NCI), a civilian agency. The award has a ceiling value of $413,765.50 and a completion date of March 23, 2026. The contract type is a purchase order with a firm fixed price. ACS is a prime contractor that has...

This $385,889 firm fixed price Phase I SBIR contract was awarded by the National Cancer Institute (NCI) to Boston Cell Standards Inc., a for-profit manufacturer of medical devices, diagnostics, and related services. Boston Cell Standards was selected under a small business set-aside to develop quantitative traceable reference materials as medical device development tools for tissue biomarkers in cancer detection. Through this prime contract, Boston Cell Standards will support NCI's cancer...

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $58,477 firm fixed price delivery order contract to the Idaho Hospital Association Inc., a non-profit organization, to conduct a Patterns of Care (POC)/Quality of Care Study on non-small cell lung cancer (NSCLC) patients diagnosed in 2017 and NSCLC and melanoma patients diagnosed in 2018. This contract is part of the NCI Patterns of Care (POC)/Quality of Care Study program and will...

The National Cancer Institute (NCI) awarded a $215,944 firm-fixed-price delivery order contract to the University of Southern California (USC) to conduct a Patterns of Care (POC)/Quality of Care Study for non-small cell lung cancer (NSCLC) diagnosed in 2017 and NSCLC and melanoma diagnosed in 2018. This contract is part of the larger Surveillance Epidemiology and End Results (SEER) program IDIQ contract, which allows NCI to issue task orders to USC for various cancer-related research and data...